American International Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-40,848
Closed -$1.86M – 3724
2016
Q1
$1.86M Sell
40,848
-27,597
-40% -$1.29M 0.01% 1143
2015
Q4
$3.69M Sell
68,445
-17,952
-21% -$944K 0.02% 884
2015
Q3
$4.26M Buy
86,397
+9,414
+12% +$540K 0.02% 803
2015
Q2
$4.49M Buy
76,983
+1,641
+2% +$95.9K 0.02% 846
2015
Q1
$4.33M Buy
75,342
+29,934
+66% +$1.64M 0.02% 853
2014
Q4
$2.29M Sell
45,408
-13,101
-22% -$638K 0.01% 1063
2014
Q3
$2.74M Sell
58,509
-891
-2% -$40.2K 0.01% 990
2014
Q2
$2.68M Sell
59,400
-5,448
-8% -$234K 0.01% 998
2014
Q1
$2.74M Sell
64,848
-78
-0.1% -$3.27K 0.01% 966
2013
Q4
$2.56M Buy
64,926
+38,331
+144% +$1.44M 0.01% 978
2013
Q3
$943K Buy
26,595
+249
+0.9% +$8.77K 0.01% 1459
2013
Q2
$875K Buy
+26,346
New +$875K 0.01% 1461

Other funds holding IHE

American International Group's IHE Position: Q2 2016 in Review

American International Group sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2016, closing a stake of 40,848 shares — an estimated $1.86M sold.

American International Group first reported a position in IHE in Q2 2013 and held it in 12 quarters. The position peaked at $4.49M in Q2 2015. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2016.

  • American International Group reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 40,848 iShares US Pharmaceuticals ETF shares in Q2 2016, an estimated $1.86M.
  • American International Group first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 12 quarters.
  • American International Group's iShares US Pharmaceuticals ETF position peaked at $4.49M in Q2 2015.
  • 87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.